Asset Details
Do you wish to reserve the book?
Determination of the 90% Effective Dose of Oliceridine Combined with Propofol for Day-Case Hysteroscopy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Determination of the 90% Effective Dose of Oliceridine Combined with Propofol for Day-Case Hysteroscopy
Do you wish to request the book?
Determination of the 90% Effective Dose of Oliceridine Combined with Propofol for Day-Case Hysteroscopy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Determination of the 90% Effective Dose of Oliceridine Combined with Propofol for Day-Case Hysteroscopy
2025
Overview
This study employed probit regression analysis to determine the 90% effective dose (ED
) of oliceridine when combined with propofol for day-case hysteroscopy.
100 patients undergoing hysteroscopic surgery were randomized to receive intravenous oliceridine (0.01, 0.015, 0.02, 0.025, or 0.03 mg kg
) 3 minutes preoperatively. Propofol was administered intravenously at 2 mg kg
induction and maintained at 6 mg kg
h
. Successful anesthesia was defined as absence of body movement during cervical dilation. Parameters recorded included the success rate, propofol consumption, total surgical duration, recovery time, postoperative pain, and adverse events.
The ED
of oliceridine for suppressing response to cervical dilation was 0.025 (95% confidence interval, CI, 0.020-0.050) mg kg
. The incidence of propofol injection pain in the 0.01, 0.015, 0.02, 0.025, and 0.03 mg kg
oliceridine groups (80%, 80%, 45%, 40%, and 30%, respectively) were significantly different (P = 0.001). There was no difference in the propofol requirements, time to anesthesia emergence, and visual analog scores(VAS) at 30 minutes postoperation among groups. No serious adverse events occurred in any patient.
For healthy adult women undergoing day-case hysteroscopy, oliceridine 0.025 mg kg
combined with propofol provides effective and safe anesthesia.
Publisher
Dove Medical Press Limited,Dove Press
Seems like something went wrong :( Kindly try again later!